Amoxicillin-Clavulanate 875/125 mg: Uses, Dosing, and Safety

What amoxicillin-clavulanate 875/125 mg is

Amoxicillin-clavulanate 875/125 mg is a prescription oral antibacterial tablet. Each tablet contains 875 mg of amoxicillin and 125 mg of clavulanic acid as the potassium salt. Augmentin is a brand associated with this combination, although available brands, generic products, and formulations may differ.

Amoxicillin belongs to the penicillin class of antibacterials. Clavulanate is a beta-lactamase inhibitor: it blocks some enzymes that can inactivate amoxicillin, helping preserve amoxicillin's activity against certain susceptible bacteria. This does not mean the combination works against every resistant bacterium, and it is not automatically the best option for every bacterial infection.

This medicine is intended for susceptible bacterial infections, not viral illnesses. It does not treat colds, influenza, or other infections caused by viruses. Taking an antibacterial when it is not needed can expose someone to side effects without treating the illness and may contribute to antibiotic resistance.

The 875/125 mg tablet is one strength among several amoxicillin-clavulanate products. Tablets, chewable products, extended-release products, and liquid suspensions can have different amounts or ratios of ingredients and should not be substituted without professional direction.

Infections it may treat-and infections it does not treat

Under the supplied U.S. labeling, amoxicillin-clavulanate may be used for certain susceptible bacterial infections involving the lower respiratory tract, middle ear, sinuses, skin and skin structures, or urinary tract. The label limits its use to infections that are proven or strongly suspected to be caused by susceptible bacteria.

A listed category is not the same as an individual diagnosis. For example, not every case of sinus symptoms, bronchitis, ear pain, skin redness, or urinary symptoms is caused by bacteria that this medicine can treat. A healthcare professional must determine whether an antibacterial is appropriate and whether this drug is a suitable choice. When available, culture and susceptibility information can help guide treatment.

Amoxicillin-clavulanate does not treat colds or flu. Antibiotics also should not be used simply because symptoms are severe or persistent without an assessment of their likely cause. Symptoms alone may not reliably distinguish viral illness from a bacterial infection.

Unnecessary or inappropriate antibacterial use can contribute to resistance, which occurs when bacteria become less responsive to medicines used against them. Resistance can make future infections more difficult to treat. The medicine should be used only when prescribed for the infection being treated, and the prescribed course should be followed rather than saved for a later illness.

How the 875/125 mg dose is prescribed and taken

For adults with more severe infections and respiratory-tract infections, the supplied U.S. label lists one 875/125 mg tablet every 12 hours as a dosing option. This is not a universal prescription. The appropriate strength, schedule, and treatment duration depend on the infection, the person's clinical circumstances, the product labeling, and the prescriber's instructions.

Take the tablet exactly as directed. Although it may be taken without regard to meals, taking it at the start of a meal enhances clavulanate absorption and is recommended to reduce gastrointestinal intolerance. Follow the prescribed schedule rather than changing the timing or taking extra tablets to make up for a dose.

If a dose is missed, take it when remembered unless it is nearly time for the next dose. If the next dose is near, skip the missed dose and resume the regular schedule. Do not take a double dose.

Do not replace one strength or formulation with another by doing dose arithmetic. For example, different tablet strengths do not necessarily contain proportional amounts of clavulanate, and liquid, chewable, extended-release, and standard tablets may not be interchangeable. Ask a pharmacist or prescriber before using a different product.

Important precautions and people who may need a different option

Amoxicillin-clavulanate should not be used by someone with a history of serious hypersensitivity to amoxicillin, clavulanate, or other beta-lactam antibacterials. A previous episode of cholestatic jaundice or liver dysfunction associated with this medicine is also a contraindication under the supplied U.S. labeling. Tell the prescriber about serious reactions to penicillins, cephalosporins, or other antibiotics rather than trying to judge independently whether a past reaction was significant.

Before treatment, disclose kidney disease, liver disease, mononucleosis, allergies, pregnancy, and breastfeeding. A history of multiple allergies may also be relevant. These details help the prescriber decide whether this medicine, a different strength, or another treatment is appropriate.

The 875/125 mg dose should not be used under the supplied U.S. labeling when GFR is below 30 mL/min. Kidney impairment may require a different strength or schedule, which must be selected by a clinician. Do not use kidney test results to adjust the dose yourself.

The label also states that amoxicillin-clavulanate should not be administered to patients with mononucleosis because amoxicillin is associated with a high rate of erythematous rash in that setting. Pregnancy and breastfeeding should be discussed before use; amoxicillin is excreted in human milk, so nursing patients should receive individualized guidance.

Common side effects and practical medication questions

Reported effects include diarrhea or loose stools, nausea, vomiting, rash or hives, and vaginal itching or discharge. In clinical-trial data cited in the U.S. label, diarrhea or loose stools occurred in 9% of participants, nausea in 3%, rash or urticaria in 3%, vomiting in 1%, and vaginitis in 1%. These are study-specific frequencies and do not predict an individual person's risk.

Taking the tablet at the start of a meal may reduce gastrointestinal intolerance while improving clavulanate absorption. Mild stomach-related symptoms can occur with this medicine, but do not change, stop, or extend prescribed treatment without discussing it with the prescriber. Persistent or troublesome symptoms deserve medical advice.

A rash requires particular caution. Some rashes may be mild, but a reader cannot always safely classify a rash without professional assessment. Contact a healthcare professional about a new or concerning rash, especially if it is spreading or accompanied by other symptoms. Hives, breathing difficulty, swelling, blistering, peeling, or shedding skin require urgent attention.

Side effects that occur during treatment are not always caused by the medicine, and not every gastrointestinal symptom indicates a serious complication. The pattern, severity, timing, and accompanying symptoms help a healthcare professional determine what action is appropriate.

Serious reactions and warning signs

Call emergency services for symptoms suggesting a severe allergic reaction, including difficulty breathing or swallowing, wheezing, or swelling of the face, lips, tongue, eyes, or throat. A widespread blistering, peeling, or shedding rash is also an emergency warning sign because it may represent a serious skin reaction.

Watery or bloody diarrhea, abdominal cramps, or fever can indicate C. difficile-associated diarrhea. This complication can occur during treatment or after antibacterial therapy, including as long as two or more months after stopping. Contact a healthcare professional promptly if these symptoms occur. Do not attempt to manage potentially serious antibiotic-associated diarrhea with antidiarrheal products without medical advice.

Possible liver injury may cause yellowing of the skin or eyes, dark urine, upper abdominal symptoms, loss of appetite, unusual tiredness, or easy bruising or bleeding. These symptoms require prompt medical contact, particularly if they develop during treatment or afterward. Serious hepatic injury has been reported with this medicine.

Not every episode of nausea, loose stool, or abdominal discomfort indicates liver injury or C. difficile infection. Severe, persistent, bloody, or worsening symptoms should not be dismissed as an ordinary side effect. A concerning rash also warrants professional assessment rather than self-classification as harmless.

Interactions, missed doses, storage, and follow-up

Tell the prescriber and pharmacist about every prescription medicine, over-the-counter product, supplement, and herbal product being used. Important interaction categories identified in the U.S. label include probenecid, oral anticoagulants such as warfarin, and allopurinol. Do not change another medicine or adjust amoxicillin-clavulanate on your own.

The medicine can also affect certain urine glucose test results. Tell healthcare professionals that you are taking amoxicillin-clavulanate before relevant testing so they can interpret results and choose appropriate testing methods.

For a missed dose, take it when remembered unless the next dose is nearly due. In that situation, skip the missed dose and continue the regular schedule. Do not double the next dose. If missed doses become frequent or the schedule is unclear, contact a pharmacist or prescriber.

Store the tablets in a tightly closed, moisture-proof container at 20° to 25°C (68° to 77°F). Liquid suspensions have different storage and discard instructions, so do not apply tablet-storage rules to a liquid product.

Contact the prescriber if symptoms do not improve, worsen, or return. Do not take extra tablets, restart a leftover prescription, or extend treatment without professional direction.

When to contact a healthcare professional

Seek emergency help for trouble breathing or swallowing, wheezing, swelling of the face or throat, or a severe blistering, peeling, or shedding rash.

Contact a healthcare professional promptly for watery or bloody diarrhea, significant cramps or fever, persistent or severe diarrhea, a concerning rash, or possible liver-warning symptoms such as yellow skin or eyes, dark urine, upper abdominal symptoms, unusual tiredness, loss of appetite, or easy bruising or bleeding.

Contact the prescriber if symptoms are not improving or are getting worse during treatment, or if symptoms remain or return after the prescribed course. These changes may require reassessment rather than an additional dose or a longer course.

Ask the prescriber or pharmacist before taking a dose if you are uncertain about the formulation, have kidney or liver disease, have a relevant allergy history, are pregnant or breastfeeding, or take medicines that may interact. Questions about missed doses, replacement tablets, or test results should also be resolved professionally.

Do not stop, restart, extend, or otherwise change treatment independently because symptoms improve or side effects occur. Medication changes require professional advice, except that severe allergic or skin-reaction symptoms require immediate emergency care.